Showing results (551-560 of 1,393) with videos related to

Sort By:
Pageof 140
JCO Precision Oncology|June 26, 2025
Minimum Technical Preanalytical, Patient, and Clinical Context Data Elements for Cerebrospinal Fluid Liquid Biopsy: Recommendations for Public Database SubmissionsStephen J Bagley, Nike Beaubier, Leonora Balaj, et al.
JCO Precision Oncology|June 26, 2025
Prospective Multicenter Study Evaluating a Combined Circulating Tumor DNA and Circulating Tumor RNA Liquid Biopsy in Metastatic Non-Small Cell Lung Cancer (LIQUIK)Jens Samol, David Ng, Jonathan Poh, et al.
JCO Precision Oncology|July 16, 2025
Real-World Germline BRCA Testing, Poly(ADP-ribose) Polymerase Inhibitor Utilization, and Survival Outcomes in Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast CancerSiddhartha Yadav, Fergus J Couch, Sam Hillman, et al.
JCO Precision Oncology|July 16, 2025
Intrapatient Variation in Response to Systemic Therapy in Advanced Hepatocellular CarcinomaPhilip J Johnson, Ellen L Boswell
JCO Precision Oncology|July 16, 2025
Quantitative Multiplex Immunofluorescence Assay for Trophoblast Cell-Surface Antigen 2 and Human Epidermal Growth Factor Receptor 2 Expression in Breast Cancer: Toward Guiding Patient Selection for Antibody-Drug Conjugate TherapiesCharles J Robbins, Mengni He, Nay Chan, et al.
JCO Precision Oncology|July 16, 2025
Safety and Tolerability of Berzosertib, an Ataxia-Telangiectasia-Related Inhibitor, and Veliparib, an Oral Poly (ADP-ribose) Polymerase Inhibitor, in Combination With Cisplatin in Patients With Refractory Solid TumorsGeraldine O'Sullivan Coyne, Khanh T Do, Shivaani Kummar, et al.
JCO Precision Oncology|July 1, 2025
Relationship Among DNA Damage Response Gene Alterations, Molecular Subtypes, and Survival Outcomes in Patients With Metastatic Bladder Cancer Treated on CALGB 90601Gopa Iyer, Woonyoung Choi, Bin Luo, et al.
JCO Precision Oncology|December 18, 2025
Minimal Residual Disease Detection in Peripheral Blood of Patients With High-Risk Neuroblastoma Correlates With Outcome in the International GPOH-DCOG Prospective Validation StudyNina U Gelineau, Lieke M J van Zogchel, Boris De Carolis, et al.
JCO Precision Oncology|December 18, 2025
Imaging- and Tumor Biomarker-Based Multivariable Model for Early Prediction of Pathologic Complete Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast CancerBeatriz E Adrada, Mary S Guirguis, Lei Huo, et al.
JCO Precision Oncology|December 22, 2025
CRESTONE: A Phase II Study of the Efficacy and Safety of the HER3 Monoclonal Antibody, Seribantumab, in Solid Tumors With Neuregulin-1 (NRG1) FusionsTejas Patil, Jessica J Lin, Parneet K Cheema, et al.
Pageof 140